These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21138197)

  • 1. Improving the accountability of California's public substance abuse treatment system through the implementation of performance models.
    Rawson RA; Gonzales R; Crèvecoeur-MacPhail D; Urada D; Brecht ML; Chalk M; Kemp J; Cunningham M
    J Psychoactive Drugs; 2010 Sep; Suppl 6():211-4. PubMed ID: 21138197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workforce professionalism in drug treatment services: impact of California's Proposition 36.
    Wu F; Hser YI
    J Subst Abuse Treat; 2011 Jan; 40(1):44-55. PubMed ID: 21036513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot-testing a statewide outcome monitoring system: overview of the California Treatment Outcome Project (CALTOP).
    Evans E; Hser YI
    J Psychoactive Drugs; 2004 May; Suppl 2():109-14. PubMed ID: 15279122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities.
    Rieckmann T; Kovas AE; Rutkowski BA
    J Psychoactive Drugs; 2010 Sep; Suppl 6():227-38. PubMed ID: 21138199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance improvement in addiction treatment: efforts in California.
    Herbeck DM; Gonzales R; Rawson RA
    J Psychoactive Drugs; 2010 Sep; Suppl 6():261-8. PubMed ID: 21138202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing performance measures for alcohol and other drug services in managed care plans. Washington Circle Group.
    McCorry F; Garnick DW; Bartlett J; Cotter F; Chalk M
    Jt Comm J Qual Improv; 2000 Nov; 26(11):633-43. PubMed ID: 11098426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the feasibility of performance measures for alcohol and other drugs.
    Garnick DW; Lee MT; Chalk M; Gastfriend D; Horgan CM; McCorry F; McLellan AT; Merrick EL
    J Subst Abuse Treat; 2002 Dec; 23(4):375-85. PubMed ID: 12495800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental health quality and accountability: the role of evidence-based practices and performance measurement.
    Ganju V
    Adm Policy Ment Health; 2006 Nov; 33(6):659-65. PubMed ID: 17053978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accountability in public short-term adult AOD residential treatment. Fontainebleau Treatment Center.
    Hyde A; Vollmerhausen S
    J Subst Abuse Treat; 1998; 15(4):367-75. PubMed ID: 9650146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention validation and accounting platform: a framework for establishing accountability and performance measures of substance abuse prevention programs.
    Kim S; McLeod JH; Williams C; Hepler N
    J Drug Educ; 2000; 30(1):1-143. PubMed ID: 10893910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of evidence-based practices for treatment of alcohol and drug disorders: the role of the state authority.
    Rieckmann TR; Kovas AE; Fussell HE; Stettler NM
    J Behav Health Serv Res; 2009 Oct; 36(4):407-19. PubMed ID: 18543111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance contracting for substance abuse treatment.
    Commons M; McGuire TG; Riordan MH
    Health Serv Res; 1997 Dec; 32(5):631-50. PubMed ID: 9402905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving care for the treatment of alcohol and drug disorders.
    McCarty D; Gustafson D; Capoccia VA; Cotter F
    J Behav Health Serv Res; 2009 Jan; 36(1):52-60. PubMed ID: 18259871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A field experiment in capitated payment systems and recovery management: the women's recovery association pilot study.
    King B; Kaplan S; Hofstedt T
    J Psychoactive Drugs; 2010 Sep; Suppl 6():287-93. PubMed ID: 21138205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. California's approach to perinatal substance abuse: toward a model of comprehensive care.
    Brindis CD; Berkowitz G; Clayson Z; Lamb B
    J Psychoactive Drugs; 1997; 29(1):113-22. PubMed ID: 9110271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating a public health approach in drug law: lessons from local expansion of treatment capacity and access under California's Proposition 36.
    Klein D; Miller RE; Noble A; Speiglman R
    Milbank Q; 2004; 82(4):723-57. PubMed ID: 15595948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCCSAPR: a new approach to drug policy research in the twenty-first century. California Collaborative Center for Substance Abuse Policy Research.
    Smith DE; Seymour RB
    J Psychoactive Drugs; 2000; 32(4):359-61. PubMed ID: 11210196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Network for the Improvement of Addiction Treatment (NIATx) Processes in Substance Use Disorder Treatment Centers.
    Fields D; Knudsen HK; Roman PM
    J Behav Health Serv Res; 2016 Jul; 43(3):354-65. PubMed ID: 25934355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.